Malignant neoplasm of lip, oral cavity and pharynx

DOID MESH PheWeb

C3_LIP_ORAL_PHARYNX

No definition available.

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions None

321302

Filter registries None

Check pre-conditions, main-only, mode, ICD version None

Check minimum number of events None

Include endpoints

C3_LIP

C3_BASEOFTONGUE

C3_TONGUENAS

C3_GUM

C3_FLOOROFMOUTH

C3_PALATE

C3_MOUTHNAS

C3_PAROTIDGLAND

C3_SALIVARYNAS

C3_TONSIL

C3_OROPHARYNG

C3_NASOPHARYNX

C3_PIRIFORMSINUS

C3_HYPOPHARYNX

C3_LIP_ORAL_PHARYNX_NAS

1322

C3_LIP_ORAL_PHARYNX

Extra metadata

Level in the ICD hierarchy 2

First used in FinnGen datafreeze DF2

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of lip, oral cavity and pharynx based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	1283	472	811
Unadjusted prevalence (%)	0.42	0.27	0.60
Mean age at first event (years)	62.04	61.45	62.39

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	0.04	3.33 [2.41, 4.62]	4.4e-13	283
15 years	0.01	1.36 [0.95, 1.93]	8.9e-2	103
5 years	0.00	2.43 [1.71, 3.46]	7.4e-7	74
1 year	-	-	-	-

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: C3_LIP_ORAL_PHARYNX – Malignant neoplasm of lip, oral cavity and pharynx
GWS hits: 0

Survival analyses between endpoints

↥

Plot

before Malignant neoplasm of lip, oral cavity and pharynx
after Malignant neoplasm of lip, oral cavity and pharynx

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Malignant neoplasm of lip, oral cavity and pharynx

↥